Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
Case Report
 
Hepatic Epithelioid Angiomyoli-poma of the Liver: A Diagnostic Dilemma
Keywords :
Bansal Nalini1, Vivek Vij2, Arif Ali2, Praveen Kumar3
1Department of Histopathology, 2Department of Liver Transplant Surgery, 3Department of Radiology, Fortis Escorts Heart Institute, New Delhi, India. 


Corresponding Author
:
Dr Nalini Bansal 
Email: drnalinibansal@yahoo.com


DOI: http://dx.doi.org/10.7869/tg.587

Epithelioid angiomyolipoma (AML) is included in group of the perivascular epithelioid cell (PEC) tumors, known as PEComas. These tumors are strongly associated with tuberous sclerosis. Most of these cases have been reported in kidney, and liver involvement is rare, with less than 50 cases described in the literature. Most cases of hepatic angiomyolipoma are misdiagnosed as adenomas or other diseases on radiology as some lack definite adipose tissue components. The final diagnosis could be reached through histology and immunohistochemistry testing.

Case Report

A 30-year-old female presented with vague abdominal pain and on evaluation was found to have a liver space-occupying lesion on ultrasound. Lab investigations showed anemia with hemoglobin of 10.5 g/dl (12-15.0 g/dl). Liver and kidney function tests were within normal limits. Contrast-enhanced CT abdomen revealed a large homogeneously hypodense mass without calcification or hemorrhage, measuring 8×7×5.5 cm in the left lobe of liver involving caudate lobe. The mass showed heterogenous centripetal arterial phase enhancement and remained slightly hyperdense, compared to normal parenchyma, on hepatic and delayed phases. A possibility of hepatic adenoma was kept based on radiological findings (Figure 1a,b).





The patient underwent segmental liver resection of the mass with the specimen showing a partly nodular partial liver segmentmeasuring 8×8×3.5 cms, with the cut surface showing a well-defined black-brown vascular mass. (Figure 2a)
Microscopic examination of the lesion showed mainly epithelioid cells arranged in sheets and trabeculae having abundant eosinophilic cytoplasm and round nuclei. (Figure 2b)There was rich vascularized stroma with thick-walled vessels. Aggregates of foam cells with fine lipid droplets noted. (Figure 2c) The neoplastic cells are diffusely positive for HMB45, and negative for HepPar 1. (Figure 2d) There were no features suggestive of aggressive behavior in the form of vascular metastasis, pleomorphism or p53 expression. 





The case was diagnosed as a hepatic epithelioid angiomyolipoma. The patient was well after resection and on regular follow up. Further evaluation for tuberous sclerosis was performed, but imaging of the brain scan was normal.  

Discussion

In 2013, the World Health Organization (WHO) defined neoplasms with perivascular epithelioid cell differentiation (PEComas) as mesenchymal tumors composed of distinctive cells that show a focal association with blood vessel walls and usually express melanocytic and smooth muscle markers.1
 PEComas include angiomyolipoma, lymphangioleiomyomatosis, and clear cell ‘sugar’ tumor.2
AML can occur anywhere in the body, but most arise in the retroperitoneum, abdominopelvic region, uterus, and gastrointestinal tract; hepatic AML is rare.3
Most cases are asymptomatic and are detected incidentally on routine examination. As the lesion enlarges, cases can present with abdominal pain. Tuberous sclerosis is associated with over half of the cases of renal AML and 5-15% cases of hepatic AML.4
Epithelioid PEComas is a variant of AML composed almost exclusively of epithelioid cells with pronounced abnormal blood vessels and few or no lipocytes.5,6 Due to the relative paucity of fat content, most cases are misdiagnosed as adenomas on radiology, as noted in our case. A definite diagnosis can be established only by histopathology and confirmed by immunohistochemical marker testing.  Most cases of epithelioid AML are found in the kidney, and liver involvement is infrequent. The presence of solitary epithelioid AML usually indicates primary hepatic EAML, and surgical excision is the treatment of choice. Multiple lesions within the liver suggest the possibility of metastasis from renal epithelioid AML and have a poor prognosis.
Brimo et al. have summarized the pathological characteristics of renal EAML likely associated with malignant progression: (1) = 2 mitotic figures per 10 high-power field; (2) atypical mitotic figures; (3) = 70% of atypical epithelioid cells; and (4) necrosis. The presence of 3 or more features was highly predictive of malignant behavior.7
The criteria for malignant transformation of hepatic epithelioid AML are not well defined due to the scarcity of these lesions.8,9 Deng et al. have postulated that large tumor size, pleomorphic nuclei with high proliferation activity, and P53 immunoreactivity may predict the existence of malignant transformation of hepatic AML.8
Due to the rare association of these tumors with tuberous sclerosis and renal lesions, further evaluation of these patients is suggested as opposed to adenomas where surgery is curative. This report aims to increase awareness among pathologists of this rare entity.  

References
  1. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. World Health Organization classification of tumours of soft tissue and bone. Fourth Edition. Vol 5. Lyon: IARC Press; 2013. pp. 230–231
  2. Hornick JL, Fletcher CD. PEComa: What do we know so far? Histopathology. 2006;48:75–82
  3. Folpe AL, Goodman ZD, Ishak KG, Paulino AF, Taboada EM, Meehan SA, et al. Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres: a novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults. Am J Surg Pathol. 2000;24:1239–1246
  4. Tsui WM, Colombari R, Portmann BC, Bonetti F, Thung SN, Ferrell LD, Nakanuma Y, Snover DC, Bioulac-Sage P, Dhillon AP. Hepatic angiomyolipoma: A clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23:34–48
  5. Ooi SM, Vivian JB, Cohen RJ. The use of the Ki-67 marker in the pathological diagnosis of the epithelioid variant of renal angiomyolipoma. Int Urol Nephrol. 2009;41:559–565.
  6. Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: The past, the present and the future. Virchows Arch. 2008;452:119–132. doi: 10.1007/s00428-007-0509-1
  7. Brimo F, Robinson B, Guo C, Zhou M, Latour M, Epstein JI. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol. 2010;34:715–722.
  8. Deng YF, Lin Q, Zhang SH, Ling YM, He JK, Chen XF. Malignant angiomyolipoma in the liver: a case report with pathological and molecular analysis. Pathol Res Pract. 2008;204:911–918
  9. Xu H, Wang H, Zhang X, Li G. [Hepatic epithelioid angiomyolipoma: a clinicopathologic analysis of 25 cases] Zhonghua Bing Li Xue Zazhi. 2014;43:685–689.